IDEXX Laboratories, Inc. (IDXX)
698.55
+26.51
(+3.94%)
USD |
NASDAQ |
Nov 04, 16:00
704.75
+6.20
(+0.89%)
After-Hours: 07:54
IDEXX Laboratories EPS Diluted (Quarterly) : 4.012 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 4.012 |
| June 30, 2026 | 4.267 |
| March 31, 2026 | 3.474 |
| December 31, 2025 | 3.084 |
| September 30, 2025 | 3.404 |
| June 30, 2025 | 3.630 |
| March 31, 2025 | 2.962 |
| December 31, 2024 | 2.619 |
| September 30, 2024 | 2.803 |
| June 30, 2024 | 2.438 |
| March 31, 2024 | 2.806 |
| December 31, 2023 | 2.318 |
| September 30, 2023 | 2.527 |
| June 30, 2023 | 2.67 |
| March 31, 2023 | 2.550 |
| December 31, 2022 | 2.055 |
| September 30, 2022 | 2.151 |
| June 30, 2022 | 1.555 |
| March 31, 2022 | 2.267 |
| December 31, 2021 | 1.890 |
| September 30, 2021 | 2.026 |
| June 30, 2021 | 2.338 |
| March 31, 2021 | 2.35 |
| December 31, 2020 | 2.011 |
| September 30, 2020 | 1.687 |
| Date | Value |
|---|---|
| June 30, 2020 | 1.724 |
| March 31, 2020 | 1.290 |
| December 31, 2019 | 1.038 |
| September 30, 2019 | 1.242 |
| June 30, 2019 | 1.435 |
| March 31, 2019 | 1.173 |
| December 31, 2018 | 0.98 |
| September 30, 2018 | 1.05 |
| June 30, 2018 | 1.23 |
| March 31, 2018 | 1.01 |
| December 31, 2017 | 0.43 |
| September 30, 2017 | 0.79 |
| June 30, 2017 | 0.95 |
| March 31, 2017 | 0.77 |
| December 31, 2016 | 0.58 |
| September 30, 2016 | 0.62 |
| June 30, 2016 | 0.74 |
| March 31, 2016 | 0.51 |
| December 31, 2015 | 0.48 |
| September 30, 2015 | 0.48 |
| June 30, 2015 | 0.60 |
| March 31, 2015 | 0.49 |
| December 31, 2014 | 0.27 |
| September 30, 2014 | 0.515 |
| June 30, 2014 | 0.5524 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Becton, Dickinson & Co. | 1.370 |
| DexCom, Inc. | 0.7215 |
| Abbott Laboratories | 0.5293 |
| Intuitive Surgical, Inc. | 1.487 |
| Teleflex, Inc. | 2.283 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 317.14M |
| Revenue (Quarterly) | 1.214B |
| Total Expenses (Quarterly) | 897.09M |
| Enterprise Value | 55.81B |
| Gross Profit Margin (Quarterly) | 63.01% |
| Profit Margin (Quarterly) | 26.12% |
| Earnings Yield | 2.12% |
| Operating Earnings Yield | 2.71% |
| Normalized Earnings Yield | 2.112 |